MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer

Santosh Lamichhane1, Ji-Su Mo2, Grinsun Sharma1

  • 1Department of Pathology, School of Medicine, Wonkwang University, Iksan, Chonbuk, 54538, Republic of Korea.

Abstract

Insights

MicroRNA 452 (MIR452) suppresses colorectal cancer (CRC) and colitis by targeting IL20RA, regulating the JAK1-STAT3 pathway. This suggests MIR452 as a potential therapeutic target for these conditions.

Area of Science:

  • Molecular Biology
  • Oncology
  • Immunology

Background:

  • MicroRNAs (miRNAs) are key regulators in biological processes, including cancer development.
  • MIR452 is upregulated in colorectal cancer (CRC) and colitis, but its functional role remains unclear.
  • Understanding MIR452's targets and pathways is crucial for CRC and colitis research.

Purpose of the Study:

  • To investigate the functional mechanisms of MIR452 in colorectal cancer and a DSS-induced colitis model.
  • To determine if MIR452 regulates IL20RA and its downstream JAK-STAT signaling pathway.
  • To elucidate the role of MIR452 as a potential therapeutic target.

Main Methods:

  • Luciferase reporter assays to confirm MIR452 targeting of IL20RA.
  • Western blot and quantitative RT-PCR to measure gene and protein expression.
  • Immunohistochemistry to assess molecular changes in CRC and colitis models.

Main Results:

  • IL20RA was identified as a direct target gene of MIR452.
  • MIR452 overexpression decreased IL20RA, JAK1, and STAT3 expression in CRC cells.
  • IL20RA knockdown reduced IL20RA, JAK1, and STAT3, but not STAT1 expression.

Conclusions:

  • MIR452 regulates STAT3 via the IL20RA-mediated JAK1 pathway, independent of STAT1.
  • MIR452 functions as a tumor suppressor in human CRC and a mouse colitis model.
  • MIR452 presents a promising therapeutic target for cancer and colitis treatment.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.0K